More due diligence will show that they have 0 patents. They licensed those patents from Air Products and since the only had $40K cash they couldn’t afford the $200K per year license fee. They even PR’d that they dropped the patents. Earlier posts of mine have the links to this. You can also see the patents disappear from the balance sheet along with the patent payable liability from last year to this year. The management commentary document accompanying the financials still shows patents but this is obviously sloppily updated and not changed as it also contains the comment that CEO Randy Torno is “expecting” his PhD in 2017 even though it is 2019.
They never had a hemp battery (only lithium) patent and in fact it would not be a monopoly as Enermat, a private company associated with Professor Mitlin at Clarkson does have a hemp energy patent which has nothing to do with ALYI.
The growing revenues are from data analytics consulting in Peru and Columbia. Nothing to do with the ALYI investment story. Most have these have never converted to cash - only to accounts receivable after several quarters - a basic accounting red flag for potential fraud. Expenses are down as they hired fewer consultants but consulting expenses are still higher than consulting revenues which are all revenues. This suggests that they are selling consulting services at a loss - either to produce revenues to PR or to pay a related party.
This is a huge red flag but not as big as the fact that CEO Randy Torno also promised a $500,000 contract, also in Kenya, while he was at ANCE, ALYI’s current business partner. These revenues never materialized and there was never an explanation from Torno or ANCE. Instead ANCE stopped issuing PRs and financials and is now skull and cross bones status on theotcmarkets.
News 
Market Data 
Discover 
